Search Result "BRAVO clinical trial"
Anticancer Drug Design Using Scaffolds of ?-Lactams, Sulfonamides, Quinoline, Quinoxaline and Natural Products. Drugs Advances in Clinical Trials
Journal: Current Medicinal Chemistry
Volume: 19 Issue: 2 Year: 2012 Page: 4377-4398
Author(s): I. Balderas-Renteria, P. Gonzalez-Barranco, A. Garcia, B. K. Banik, G. Rivera
The Antithrombotic Efficacy of Lotrafiban (SB 214857) in Canine Models of Acute Coronary Thrombosis
Journal: Current Drug Targets - Cardiovascular & Hematological Disorders
Volume: 2 Issue: 1 Year: 2002 Page: 13-25
Author(s): John R.Toomey, James Samanen, Richard E. Valocik, Paul F. Koster, Frank C. Barone, Robert N. Willette
PARP Inhibitor Drugs in the Treatment of Breast, Ovarian, Prostate and Pancreatic Cancers: An Update of Clinical Trials
Journal: Current Drug Targets
Volume: 19 Issue: 1 Year: 2018 Page: 21-37
Author(s): Dalia Kamel,Christopher Gray,Jagdeep Singh Walia,Vikaash Kumar
Effects of Coffee Supplementation on Homocysteine and Leptin Levels: A Systematic Review and Meta-analysis of Clinical Trials
Journal: Current Pharmaceutical Design
Volume: 29 Issue: 1 Year: 2023 Page: 30-36
Author(s): Luis E. Simental-MendÃa
Dendritic Cell Immunotherapy for Melanoma
Journal: Reviews on Recent Clinical Trials
Volume: 1 Issue: 2 Year: 2006 Page: 87-102
Author(s): Judy C. Peng, Ranjeny Thomas, Keith Dredge
Clinical Proteomics of Breast Cancer
Journal: Current Genomics
Volume: 11 Issue: 7 Year: 2010 Page: 528-536
Author(s): Y. Baskin, T. Yigitbasi
Platelet Glycoprotein IIb / IIIa Inhibition and its Clinical Use
Journal: Current Medicinal Chemistry - Cardiovascular & Hematological Agents
Volume: 2 Issue: 3 Year: 2004 Page: 187-196
Author(s): Fengyang Huang, Enrique Hong
The TRIGR Trial: Testing the Potential Link between Weaning Diet and Type 1 Diabetes
Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry
Volume: 7 Issue: 3 Year: 2007 Page: 251-263
Author(s): Hans K. Akerblom, Mikael Knip, Dorothy Becker, Hans-Michael Dosch, John Dupre, Jorma Ilonen, Jeffrey P. Krischer, The TRIGR Study Group
Recent Advances of mTOR Inhibitors Use in Autosomal Dominant Polycystic Kidney Disease: Is the Road Still Open?
Journal: Current Medicinal Chemistry
Volume: 26 Issue: 16 Year: 2019 Page: 2962-2973
Author(s): Pei Kou,Shuang Wei,Fei Xiong
Antiepileptic Drug Interactions - Principles and Clinical Implications
Journal: Current Neuropharmacology
Volume: 8 Issue: 3 Year: 2010 Page: 254-267
Author(s): Svein I. Johannessen, Cecilie Johannessen Landmark